As the chief executive officer of TMGcore, JD Enright oversees global operations, and is responsible for both regulatory affairs and core product development, among other areas. JD Enright works with the global head of commercial manufacturing and other C-suite executives to develop and commercialize products and services which encorporate thier patented two-phase liquid immersion computing technology. In the role, he draws on an extensive career in technolgy leadership. With Lonza, Mr. Enright served as Sr. Director of its Global Strategic Growth Investments Group and held the position of General Manager and its emerging technologies division during which time he oversaw its Viral Cell and Gene Therapy growth program in Houston. Through the initiative, he directed the creation of the world's largest R&D and Commercial viral cell therapy campus. The center, which spans 19 acres, uses state of the art technology and features commercial and clinical manufacturing techniques. In managing the project, JD Enright was responsible for obtaining investment capital alongside overseeing its development.